T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Airlines Group
AAL
|
+$1.21B |
| 2 |
RTX Corp
RTX
|
+$1.14B |
| 3 |
PepsiCo
PEP
|
+$1.12B |
| 4 |
ASML
ASML
|
+$817M |
| 5 |
Wynn Resorts
WYNN
|
+$798M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.24B |
| 2 |
Mastercard
MA
|
+$1.08B |
| 3 |
Qualcomm
QCOM
|
+$972M |
| 4 |
eBay
EBAY
|
+$898M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$748M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.86% |
| 2 | Consumer Discretionary | 13.55% |
| 3 | Financials | 13.21% |
| 4 | Industrials | 12.32% |
| 5 | Technology | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OXFD
1151
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $17.2M | ﹤0.01% |
855,300
+1,400
| +0.2% | +$30.3K |
|
|
OREX
1152
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $17.1M | ﹤0.01% |
263,451
+258,991
| +5,807% | +$17.5M |
|
1153
Capital Southwest
CSWC
$1.61B
| $17M | ﹤0.01% |
1,337,048
+1,634
| +0.1% | +$20.8K |
|
|
AXE
1154
DELISTED
Anixter International Inc
AXE
| $17M | ﹤0.01% |
167,800
+7,000
| +4% | +$684K |
|
|
QCOR
1155
DELISTED
QUESTCOR PHARMA INC
QCOR
| $17M | ﹤0.01% |
261,800
-15,600
| -6% | -$996K |
|
1156
Ameren
AEE
$30.2B
| $16.9M | ﹤0.01% |
411,209
+6,790
| +2% | +$262K |
|
|
STML
1157
DELISTED
Stemline Therapeutics, Inc.
STML
| $16.9M | ﹤0.01% |
830,266
-46,400
| -5% | -$1.13M |
|
1158
Lincoln Electric
LECO
$15.5B
| $16.9M | ﹤0.01% |
234,683
-7,497
| -3% | -$538K |
|
1159
Nektar Therapeutics
NKTR
$2.57B
| $16.9M | ﹤0.01% |
92,893
-2,907
| -3% | -$575K |
|
|
SLXP
1160
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $16.9M | ﹤0.01% |
162,973
+2,600
| +2% | +$266K |
|
1161
WEC Energy
WEC
$35.9B
| $16.8M | ﹤0.01% |
361,570
-6,310
| -2% | -$272K |
|
1162
BioCryst Pharmaceuticals
BCRX
$2.51B
| $16.7M | ﹤0.01% |
+1,583,000
| New | +$16.9M |
|
1163
Hooker Furnishings Corp
HOFT
$158M
| $16.7M | ﹤0.01% |
1,065,990
+800
| +0.1% | +$12.4K |
|
|
CRRC
1164
DELISTED
COURIER CORP
CRRC
| $16.6M | ﹤0.01% |
1,081,010
+3,000
| +0.3% | +$49.1K |
|
1165
Utah Medical Products
UTMD
$230M
| $16.5M | ﹤0.01% |
285,403
+5,247
| +2% | +$286K |
|
|
GTAT
1166
DELISTED
GT ADVANCED TECHNOLOGIES INC COM STK (DE)
GTAT
| $16.4M | ﹤0.01% |
963,960
-1,847,000
| -66% | -$23.8M |
|
|
CETV
1167
DELISTED
Central European Media Enterprises Ltd
CETV
| $16.4M | ﹤0.01% |
5,579,772
+3,328,375
| +148% | +$11M |
|
|
UTIW
1168
DELISTED
UTI WORLDWIDE INC
UTIW
| $16.3M | ﹤0.01% |
1,540,880
+3,600
| +0.2% | +$51.3K |
|
1169
Sprott Physical Gold and Silver Trust
CEF
$8.17B
| $16.3M | ﹤0.01% |
1,185,570
+1,200
| +0.1% | +$17.1K |
|
1170
NVIDIA
NVDA
$5.46T
| $16.3M | ﹤0.01% |
36,375,040
+212,000
| +0.6% | +$90.7K |
|
|
GRA
1171
DELISTED
W.R. Grace & Co.
GRA
| $16.1M | ﹤0.01% |
162,474
-17,726
| -10% | -$1.75M |
|
|
PENX
1172
DELISTED
PENFORD CORP
PENX
| $16M | ﹤0.01% |
1,112,300
| – | – |
|
|
CLNY
1173
DELISTED
Colony Capital, Inc.
CLNY
| $15.9M | ﹤0.01% |
723,730
+1,750
| +0.2% | +$38.5K |
|
|
LLL
1174
DELISTED
L3 Technologies, Inc.
LLL
| $15.9M | ﹤0.01% |
134,239
+100
| +0.1% | +$11.2K |
|
1175
lululemon athletica
LULU
$13.6B
| $15.7M | ﹤0.01% |
298,442
-3,199,605
| -91% | -$160M |
|
Similar funds
T. Rowe Price Associates's Q1 2014 Portfolio in Review
As of Q1 2014, T. Rowe Price Associates held 2,567 positions worth $445B, up 2% from $436B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q1 2014 filing shows 89 new, 904 increased, 825 reduced and 68 closed positions. Its largest new stake was Liberty Global Class C: 13,695,496 shares worth $451M. The largest sale was Apple, an estimated $1.24B.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2014 buy was Liberty Global Class C: 13,695,496 shares worth $451M.
- T. Rowe Price Associates added most to American Airlines Group in Q1 2014, an estimated $1.21B increase.
- T. Rowe Price Associates's biggest Q1 2014 reduction was Apple, cutting an estimated $1.24B.
- T. Rowe Price Associates fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $200M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $445B portfolio in Q1 2014.
- T. Rowe Price Associates opened 89 new positions and closed 68 in Q1 2014.
- T. Rowe Price Associates's portfolio value rose 2% quarter-over-quarter to $445B.
Based on T. Rowe Price Associates's 13F filing for Q1 2014, filed 15 May 2014.